Comparing Trimetazidine with Allopurinol in Prevention of Contrast Induced Nephropathy After Coronary Angiography
Galal, Haitham; Shehta, Mahmoud; Attia, Sameh; Bastawy, Islam;
Abstract
Contrast-induced nephropathy is considered a serious complication following coronary angiography increasing morbidity and mortality. Various drugs have been assessed to reduce the incidence of contrast-induced nephropathy. In this study, we compared trimetazidine and allopurinol as a pharmacological measure to reduce the incidence of contrast-induced nephropathy.
Other data
| Title | Comparing Trimetazidine with Allopurinol in Prevention of Contrast Induced Nephropathy After Coronary Angiography | Authors | Galal, Haitham; Shehta, Mahmoud; Attia, Sameh; Bastawy, Islam | Keywords | Acute kidney injury;Interventional cardiology;Contrast-induced nephropathy;Contrast volume | Issue Date | 21-Oct-2020 | Publisher | DIGITAL COMMONS BEPRESS | Journal | Journal of the Saudi Heart Association | Volume | 32 | Issue | 3 | ISSN | 1016-7315 | DOI | 10.37616/2212-5043.1146 | PubMed ID | 33299790 | Web of science ID | WOS:000588732200010 |
Attached Files
| File | Description | Size | Format | Existing users please Login |
|---|---|---|---|---|
| Comparing Trimetazidine with Allopurinol in Prevention of Contrast Induced Nephropathy After Coronary Angiography.pdf | 146.77 kB | Adobe PDF | Request a copy |
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.